Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Arylamine N-acetyltransferase-1 (
NAT1
) is a polymorphically expressed enzyme that is widely distributed throughout the body. In the present study, we provide evidence for substrate-dependent regulation of this enzyme. Human peripheral blood mononuclear cells cultured in medium supplemented with p-aminobenzoic acid (PABA; 6 microM) for 24 h showed a significant decrease (50-80%) in
NAT1
activity. The loss of activity was concentration-dependent (EC(50) approximately 2 microM) and selective because PABA had no effect on the activity of constitutively expressed lactate dehydrogenase or
aspartate aminotransferase
. PABA also induced down-regulation of
NAT1
activity in several human cell lines grown at confluence. Substrate-dependent down-regulation was not restricted to PABA. Addition of other
NAT1
substrates, such as p-aminosalicylic acid, ethyl-p-aminobenzoate, or p-aminophenol to peripheral blood mononuclear cells in culture also resulted in significant (P <.05) decreases in
NAT1
activity. However, addition of the NAT2-selective substrates sulfamethazine, dapsone, or procainamide did not alter
NAT1
activity. Western blot analysis using a
NAT1
-specific antibody showed that the loss of
NAT1
activity was associated with a parallel reduction in the amount of
NAT1
protein (r(2) = 0.95). Arylamines that did not decrease
NAT1
activity did not alter
NAT1
protein levels. Semiquantitative reverse transcriptase polymerase chain reaction of mRNA isolated from treated and untreated cells revealed no effect of PABA on
NAT1
mRNA levels. We conclude that
NAT1
can be down-regulated by arylamines that are themselves
NAT1
substrates. Because
NAT1
is involved in the detoxification/activation of various drugs and carcinogens, substrate-dependent regulation may have important consequences with regard to drug toxicity and cancer risk.
...
PMID:Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. 1069 86